These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 33658780)
1. Dual Functional Eudragit Gao C; Yu S; Zhang X; Dang Y; Han DD; Liu X; Han J; Hui M Int J Nanomedicine; 2021; 16():1405-1422. PubMed ID: 33658780 [TBL] [Abstract][Full Text] [Related]
2. Protective Effect of Iridoid Glycosides of the Leaves of Syringa oblata Lindl. on Dextran Sulfate Sodium-Induced Ulcerative Colitis by Inhibition of the TLR2/4/MyD88/NF- Zhang Y; Han D; Yu S; An C; Liu X; Zhong H; Xu Y; Jiang L; Wang Z Biomed Res Int; 2020; 2020():7650123. PubMed ID: 32337275 [TBL] [Abstract][Full Text] [Related]
3. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519 [TBL] [Abstract][Full Text] [Related]
4. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis. Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486 [TBL] [Abstract][Full Text] [Related]
5. Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis. Wang A; Liu Y; Xiong W; Li W; Li J; Yang Z; Zou Z; Luo Y; Chen Z; Li H; Vong CT; Zou L J Pharm Sci; 2024 Sep; 113(9):2744-2755. PubMed ID: 38901529 [TBL] [Abstract][Full Text] [Related]
6. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy. Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440 [TBL] [Abstract][Full Text] [Related]
7. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy. Xiao B; Si X; Zhang M; Merlin D Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840 [TBL] [Abstract][Full Text] [Related]
8. Drug release in vivo and efficacy evaluation of a new colon targeted powder of total saponins of Pulsatilla. Chen Z; Zhao T; Zhou L; Kang J; Guan Y; Yang M; Yang S; Liu H Biomed Pharmacother; 2020 Sep; 129():110376. PubMed ID: 32563985 [TBL] [Abstract][Full Text] [Related]
9. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy. Wang X; Gu H; Zhang H; Xian J; Li J; Fu C; Zhang C; Zhang J ACS Appl Mater Interfaces; 2021 Jul; 13(29):33948-33961. PubMed ID: 34261306 [TBL] [Abstract][Full Text] [Related]
11. Eudragit S100 coated iron oxide-chitosan nanocomposites for colon targeting of 5-aminosalicylic acid ameliorate ulcerative colitis by improving intestinal barrier function and inhibiting NLRP3 inflammasome. Zhang D; Wan H; Zhao R; Zhang Y; Chen H Int Immunopharmacol; 2024 Sep; 139():112661. PubMed ID: 39008936 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of 5-ASA and hesperidin-loaded chitosan/Eudragit® S100 nanoparticles as a pH-sensitive carrier for local targeted drug delivery in a rat model of ulcerative colitis. Abdollahy A; Salehi M; Mahami S; Bernkop-Schnürch A; Vahedi H; Gharravi AM; Mehrabi M Int J Pharm; 2024 Mar; 652():123838. PubMed ID: 38266937 [TBL] [Abstract][Full Text] [Related]
13. Iridoid glycosides fraction of Folium syringae leaves modulates NF-κB signal pathway and intestinal epithelial cells apoptosis in experimental colitis. Liu X; Wang JM PLoS One; 2011; 6(9):e24740. PubMed ID: 21931839 [TBL] [Abstract][Full Text] [Related]
14. Glycogen-based pH and redox sensitive nanoparticles with ginsenoside Rh Xu Y; Zhu BW; Li X; Li YF; Ye XM; Hu JN Biomaterials; 2022 Jan; 280():121077. PubMed ID: 34890974 [TBL] [Abstract][Full Text] [Related]
15. Micro- and Nanoencapsulated Hybrid Delivery System (MNEHDS): A Novel Approach for Colon-Targeted Oral Delivery of Berberine. Zhang L; Li M; Zhang G; Gao C; Wang S; Zhang T; Ma C; Wang L; Zhu Q Mol Pharm; 2021 Apr; 18(4):1573-1581. PubMed ID: 33629860 [TBL] [Abstract][Full Text] [Related]
16. Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease. Zeeshan M; Ali H; Khan S; Mukhtar M; Khan MI; Arshad M Nanomedicine (Lond); 2019 Aug; 14(15):1945-1969. PubMed ID: 31355705 [No Abstract] [Full Text] [Related]
17. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis. Ali AS; Altayari AA; Khan LM; Alharthi SE; Ahmed OA; El-Shitany NA; Ali SS; Saadah OI Pharmacology; 2020; 105(9-10):541-549. PubMed ID: 31940656 [TBL] [Abstract][Full Text] [Related]
18. A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitis. Wu Y; Sun M; Wang D; Li G; Huang J; Tan S; Bao L; Li Q; Li G; Si L Biomater Sci; 2019 Oct; 7(10):4299-4309. PubMed ID: 31408067 [TBL] [Abstract][Full Text] [Related]
19. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis. Naeem M; Lee J; Oshi MA; Cao J; Hlaing SP; Im E; Jung Y; Yoo JW Acta Biomater; 2020 Oct; 116():368-382. PubMed ID: 32937207 [TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis. Zhou H; Qian H Drug Des Devel Ther; 2018; 12():2601-2609. PubMed ID: 30174414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]